In the areas of mergers and acquisitions, greenfield investments, and joint ventures, Ms. Chen’s recent representative M&A experience includes: representing Warburg Pincus in the acquisition of equity in Zhen Shi Ming Pharmaceuticals through a property exchange, representing Warburg Pincus in the sale of its oil and gas assets in China to a listed company in Hong Kong, representing Alibaba in its acquisitions of multiple high-tech companies, representing Goertek Inc. (an A-share listed company) in the merger of its optical business with Sunny Optical (a Hong Kong-listed company), representing AUO (a Taiwan-listed company) in bidding for the acquisition of a German automobile manufacturer, representing a Singaporean exhibition company in its intended bid to acquire Chinese exhibition companies, representing Nitech in its acquisition by Genesis Medtech, representing Ingage in its sale of majority stake to Tencent;
Ms. Chen’s recent representative greenfield investments and joint venture experience includes: representing a state-owned energy enterprise’s greenfield investment in a photovoltaic power station project in the Democratic Republic of the Congo, representing a multinational corporation in the metal industry for its greenfield investment in China to establish and construct a copper smelter project with a local partner; representing a state-owned energy enterprise in establishing a joint venture with a local partner in Kazakhstan, representing a Singapore-listed company in its intended joint venture to establish a data center business in China, representing Alibaba in establishing a joint venture with Richemont Group and Farfetch, representing EasyPnP in establishing a joint venture with Mitsui, representing Zanadu Travel in establishing a joint venture with the Australian company Luxury Escapes.
In the area of private equity investments, Ms. Chen has represented numerous renowned investment institutions, including Warburg Pincus, GIC, Hillhouse Capital, HongShan China, IDG Capital, Gaorong Capital, CDH, SAIF Partners, Alibaba, Tencent, ByteDance, China Mobile,CICC Capital, Sinopec Enze, Oriza Holdings, and China Life Technology Innovation, in extensive strategic investments, financial investments, and restructuring transactions. Ms. Chen’s recent experience representing both investors and companies includes: Horizon Robotics, EcoFlow, iFlytek Healthcare, Hongene Biotech, Longping Biology, Cowell Health, UniVista, Manbang, ROX Motor, Dexmal, Noematric, Moodytiger, Hive Box, Double FS, Miracle Miles, Moody, EMQ Technologies, XAG, Iris, LinkCure, SmartMore, RoboGo, and Future Robot.
In the area of capital markets, Ms. Chen’s recent representative experience includes: representing an autonomous driving company in its initial public offering and listing in the United States, representing an innovative pharmaceutical company in its initial public offering and listing in Hong Kong, representing an investor in the initial public offering and listing of a SaaS company in Hong Kong, and representing an investor in the initial public offering and listing of a comprehensive hospital in Hong Kong.
In the area of general corporate matters, Ms. Chen’s recent representative experience includes: representing a central state-owned enterprise in the oil, gas and energy sectors, providing operational legal services for its multiple oil and gas and renewable energy projects in Central Asia; representing a state-owned enterprise in the field of energy sector, offering legal services for its business operations and corporate governance.